Marshall Wace, LLP Atri Cure, Inc. Call Options Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ATRC
# of Institutions
212Shares Held
49.7MCall Options Held
12KPut Options Held
7.2K-
Vanguard Group Inc Valley Forge, PA4.66MShares$168 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$166 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.97MShares$143 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.83MShares$102 Million1.47% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.79MShares$101 Million0.5% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.67B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...